Filing Flows › Integer Holdings (ITGR) › Cardiac Rhythm Management & Neuromodulation revenue
Integer Holdings (ITGR) Cardiac Rhythm Management & Neuromodulation revenue by quarter
Integer Holdings' Cardiac Rhythm Management & Neuromodulation revenue was $176M in Q3 2026 (third quarter 2026), +1% from Q2 2026. Over the last 3 quarters it ranged from $168M (Q1 2026) to $176M (Q3 2026).
| Quarter | Cardiac Rhythm Management & Neuromodulation revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $176M | +1% | — |
| Q2 2026 | $174M | +3% | — |
| Q1 2026 | $168M | — | — |
Q3 2026 at a glance
Integer Holdings, Q3 2026: revenue $450M (-4% year over year), operating margin 6.3%, net earnings $15.0M, operating cash flow $36.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Integer Holdings' Cardiac Rhythm Management & Neuromodulation revenue?
Integer Holdings' Cardiac Rhythm Management & Neuromodulation revenue was $176M in Q3 2026 (third quarter 2026), +1% from Q2 2026.
How has Integer Holdings' Cardiac Rhythm Management & Neuromodulation revenue changed?
Over the last 3 quarters it ranged from $168M (Q1 2026) to $176M (Q3 2026).